Loading...
Prognostic Value of Blasts in Peripheral Blood in Myelofibrosis in the Ruxolitinib Era
BACKGROUND: Peripheral blasts (PB) ≥1% have long been considered an unfavorable feature for patients with primary myelofibrosis (PMF). Whether further quantification of PB blasts and their correlation with bone marrow (BM) blasts has incremental value with regards to patient prognostication is uncle...
Na minha lista:
| Udgivet i: | Cancer |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7875207/ https://ncbi.nlm.nih.gov/pubmed/32697338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.33094 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|